Viewing Study NCT01252732


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-01-18 @ 9:12 AM
Study NCT ID: NCT01252732
Status: COMPLETED
Last Update Posted: 2021-05-05
First Post: 2010-12-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
Sponsor: Melinta Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Wound Infection View
None Abscess View
None Systemic Inflammation View
None Cellulitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ABSSSI View
None Skin Infection View
None Abscess View